The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCLL 2017 | Is effective management of CLL as a chronic disease as good as a ‘”cure”?
Arnon Kater, MD, PhD from the University of Amsterdam, Amsterdam, Netherlands discusses the concept of developing a cure for chronic lymphocytic leukemia (CLL). Prof. Arnon describes the risks often involved with procedures such as allogeneic transplants performed to “cure” patients. As an alternative, using new, available drugs to make CLL a truly chronic disease that can be controlled, is not only achievable but can allow the patients to have a good quality of life. This interview was recorded at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2017 held in New York, NY.
